Modzatinib

N/A

Report date: 2026/03/11 20:02:12
NME

Base Information

Drug NameModzatinib
Drug Alias NameATI-2138
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK3 inhibitorsTyrosine-protein kinase ITK/TSK inhibitors
TargetsTyrosine-protein kinase JAK3Tyrosine-protein kinase ITK/TSK
Therapy Area/IndicationsAutoimmune DiseasesPsoriasisAlopecia Areata +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesConfluence Life Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAclaris Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesPsoriasisAlopecia Areata +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A